Novartis Animal Health presents varied symposium

©

©

Dr Nathan Winkelmann kicked off the session by presenting the effect of Denagardwater medication against ileitis under field conditions and in challenge studies. He showed that dosage at 60ppm showed excellent efficacy in pigs challenged with a high level of Lawsonia intracellularis. “Higher levels (120ppm+) and longer treatment periods may be warranted in severe outbreaks or in eradication efforts in which elimination of faecal shedding is the goal” explained Winkelmann.

©

Dr Jake Waddilove explained the establishment of swine dysentery eradication programmes – practical experiences from the UK. Waddilove explained that after the introduction of the Swine Dysentery Producers Charter in the UK, swine dysentery was fully eliminated from the area (East Anglia). Waddilove: “Programmes like these help the producer in giving openness and stimulates to cooperate between producers to control pig diseases.”

©

Dr Fabrizio Agnoletti talked about the genetic characterisation and antimicrobial susceptibility of Clostridium perfringens and Clostridium difficile isolates from neonatal piglets. According to Agnoletti, Tiamulin proves to be a good weapon against clostridia species involved in enteritis cases in pigs. He addressed that geographical differences in the susceptibility profile of clostridia species suggest the need of local sensitivity testing for final drug selection for therapeutic application.

©

Dr David Burch had an interesting talk about pharmakinetic and pharmacodynamic relationships of tialmulin (Denagard®) for enteric and respiratory infections in pigs. Dr Steven McOrist ended the symposium by speeching about the role of vectors in disease transfer, which highlighted the fact that we should include proper insect (flies, cockroaches) control measures in the pig biosecurity plan.

©

©